If you've ever waited anxiously for a Medicare Advantage plan to approve a surgery, a specialist visit, or a medical device your doctor ordered, you've experienced prior authorization firsthand. That approval process — where your insurer decides whether a treatment is medically necessary before agreeing to pay — has been one of the most complained-about features of Medicare Advantage for years. Now, a combination of new federal regulations and voluntary industry commitments is beginning to change how those decisions get made, and how fast. Understanding exactly what has changed, and what hasn't, can help you navigate your plan more effectively and push back when something goes wrong.
Prior authorization exists in virtually every Medicare Advantage plan sold in the United States. Unlike Original Medicare (Parts A and B), which generally pays for any service that meets coverage criteria without pre-approval, Medicare Advantage plans — the private insurance alternative that covers about 33 million beneficiaries as of 2025 — are permitted to require prior authorization as a cost-management tool. The problem, documented in multiple federal audits and a 2022 Senate Finance Committee investigation, is that plans have sometimes used prior authorization to delay or deny care that should clearly be covered. The HHS Office of Inspector General found in 2022 that Medicare Advantage plans denied 13 percent of prior authorization requests that met Medicare coverage rules — meaning care that Original Medicare would have paid for was being blocked.
The regulatory side of this reform story centers on a CMS rule that took effect in 2024 and continues to be enforced and refined heading into 2026. Under that rule, Medicare Advantage plans must respond to standard prior authorization requests within 7 calendar days — a significant tightening from the previous 14-day window. For urgent or expedited requests, where a delay could seriously harm your health, plans must respond within 72 hours. Plans are also now required to provide a specific clinical reason when they deny a request, not just a vague reference to medical necessity criteria. That specificity matters enormously when you or your doctor decides to appeal, because a denial letter that cites a precise policy gives you something concrete to challenge.
The same CMS rule introduced new transparency requirements. Medicare Advantage plans must now publicly report their prior authorization approval and denial rates, broken down by service category. That data, posted on Medicare.gov and through CMS's public reporting tools, allows beneficiaries and advocacy groups to compare how aggressively different plans use prior authorization. If you're shopping during the Annual Enrollment Period (October 15 through December 7 each year) or the Open Enrollment Period (January 1 through March 31), checking a plan's prior authorization denial rate for services you use regularly — say, home health, durable medical equipment, or outpatient surgery — can be just as important as comparing premiums and copays. A plan with a $0 premium but a high denial rate for the services you need may cost you far more in delayed care and out-of-pocket spending.
Beyond the regulatory requirements, several of the largest Medicare Advantage insurers — including UnitedHealthcare, Humana, CVS Health/Aetna, and Elevance Health — have made voluntary commitments in recent years to reduce the volume of services requiring prior authorization. These pledges have included removing prior authorization requirements for certain post-acute care services like skilled nursing facility stays following a hospitalization, and streamlining approvals for physicians who have demonstrated consistent compliance with coverage criteria (a concept sometimes called "gold carding"). The practical effect for beneficiaries is real: fewer hoops to jump through for routine or predictable care. However, it's critical to understand that voluntary commitments are not the same as enforceable regulations. A plan can modify or walk back a voluntary policy without the public comment process and legal accountability that accompany a CMS rulemaking. When you're evaluating a plan's prior authorization practices, look at what the plan's Evidence of Coverage document actually requires — that's the legally binding document — not just what a company announced in a press release.
If your Medicare Advantage plan denies a prior authorization request, you have a structured set of rights that many beneficiaries don't fully use. First, your doctor can request a peer-to-peer review — a direct conversation between your physician and the plan's medical reviewer. Studies and anecdotal reports from physicians suggest this step reverses a meaningful share of initial denials, particularly when the treating doctor can explain clinical nuances that weren't captured in the original paperwork. Second, you can file a formal appeal. The first level is called a redetermination, and the plan must respond within 30 days for standard appeals or 72 hours for expedited appeals. If the plan upholds the denial, you can escalate to an independent review by a Qualified Independent Contractor (QIC), then to an Administrative Law Judge, and ultimately to federal court. The Medicare Appeals Council data shows that beneficiaries who appeal — especially to the independent review stage — win a significant portion of their cases. Don't assume a denial is final.
State-level action is adding another layer to this reform picture. Several states have passed or are considering "gold carding" laws that require insurers to exempt physicians with strong track records from prior authorization requirements for specific services. As of 2025, more than 20 states have enacted some form of prior authorization reform legislation affecting commercial and Medicaid managed care plans, and some of those protections extend to Medicare Advantage plans operating in those states, depending on how the law is written. If you live in a state with active prior authorization legislation, your state insurance commissioner's office can tell you which protections apply to your specific plan type.
For beneficiaries managing chronic conditions — heart disease, diabetes, COPD, cancer — prior authorization friction can have real health consequences. A 2023 American Medical Association survey found that 94 percent of physicians reported that prior authorization delays had led to patients abandoning recommended treatment, and 33 percent said a patient had experienced a serious adverse event as a result of a prior authorization delay. These aren't abstract statistics. If you or a family member is waiting on an approval for chemotherapy, a cardiac procedure, or a specialty medication, knowing your rights and the specific timelines your plan must follow can make a tangible difference. Keep a written log of every prior authorization request: the date submitted, the service requested, the plan's response deadline under the 7-day or 72-hour rule, and the date you actually received a decision. That documentation is your evidence if you need to escalate.
Looking ahead into 2026, CMS has signaled continued attention to prior authorization as part of its broader Medicare Advantage oversight agenda. The agency has proposed additional requirements around the use of artificial intelligence and algorithmic tools in coverage decisions — a growing concern after investigative reporting revealed that some plans were using AI-driven systems to generate denial decisions with minimal physician review. Proposed rules would require that any denial of a prior authorization request be reviewed by a qualified clinician, not just an automated system. That rulemaking is still working through the regulatory process, but it reflects the direction CMS is heading. Beneficiaries who want to track these developments can monitor the CMS Medicare Advantage and Part D page at cms.gov, where proposed and final rules are posted for public comment.